Dr. Lingvay graduated from medical school among the top 5% of her class. She completed the Internal Medicine Residency at Texas Tech University in 2002, and Endocrinology, Diabetes and Metabolism Fellowship at University of Texas Southwestern Medical Center in 2005. Dr. Lingvay was selected to participate in the first class of the Clinical Research Scholars Program at UT Southwestern which she completed in 2008. In 2007 she received a National Institute of Health Career Development Award to study the role of pancreatic triglyceride accumulation in beta-cell failure and type 2 diabetes and to further develop her career as a clinical investigator. Dr. Lingvay also received the Master in Public Health degree from University of Texas School of Public Health in Houston in 2006.


Medical School
Carol Davila University of Medicine & Pharmacy (1998)
Texas Tech University Health Sciences Center (2000), Internal Medicine
UT Southwestern Medical Center (2005), Endocrinology & Metabolism
Graduate School
University of Texas Health Science Center at Houston (2006)

Specialty Areas

Clinical Interest

  • Endocrine Cancers
  • Polycystic Ovary Disease (PCOS)
  • Thyroid Cancer, Masses & Tumors
  • Research Interest

    • Metabolic Syndrome
    • Obesity
    • Type 2 Diabetes Mellitus


    Featured Publications LegendFeatured Publications

    Pancreatic Steatosis - Harbinger of Type 2 Diabetes in Obese Rodents
    Lee Y, Lingvay I, Szczepaniak LS, Orci L, Unger RH Internal Journal of Obesity Fall 2010 34/2 396-400
    Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?
    Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P Diabetes Care October 2009 32/10 1789-95
    Noninvasive quantification of pancreatic fat in humans
    Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS The Journal of Clinical Endocrinology & Metabolism Fall 2009 94/10 4070-6
    Trends in thyroid cancer demographics and surgical therapy in the United States
    Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, Nwariaku FE Surgery December 2007 142/6 823-8
    Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes
    Zib I, Jacob AN, Lingvay I, Salinas K, McGavock JM, Raskin P, Szczepaniak LS Journal of Investigative Medicine July 2007 55/5 230-6

    Professional Associations/Affiliations

    • American Diabetes Association
    • American Federation for Medical Research
    • Association of Program Directors in Endocrinology, Diabetes and Metabolism
    • European Association for the Study of Diabetes
    • The Endocrine Society